Učitavanje...
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
PURPOSE: Recent clinical trials have demonstrated that zoledronic acid (ZOL) significantly prolongs survival in prostate cancer patients undergoing androgen deprivation therapy. This pilot study investigated the influence of ZOL on circulating tumor cell (CTC) counts in prostate cancer patients in a...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Asian Pacific Prostate Society (APPS)
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4186959/ https://ncbi.nlm.nih.gov/pubmed/25325027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12954/PI.14056 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|